← Open Payments lookup

WILLIAM ONDO: Open Payments

NPI 1851471437 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$217,109 in 308 payments from 22 companies in 2025. Trend: 2023 $261,808 · 2024 $209,609 · 2025 $217,109

Speaker / faculty: $128,165Consulting: $34,815Honoraria: $28,752Travel & lodging: $17,314Food & beverage: $6,615Education: $1,448
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.42$57,972
MDD US Operations, LLC56$38,378
ACADIA Pharmaceuticals Inc43$37,421
Neurocrine BioSciences, Inc.45$30,896
ABBVIE INC.55$21,767
Merz Pharmaceuticals, LLC26$16,985
Amneal Pharmaceuticals LLC12$7,641
UCB SA2$2,240
ORPHALAN INC1$1,800
Ipsen Pharma SAS1$750

Products named: AUSTEDO XR, INGREZZA, NUPLAZID, INBRIJA, BOTOX, CREXONT, Gocovri, ACP-711.

Industry payments across TX — which companies pay providers there.